Sutter Health Helps Develop Comprehensive Diabetes Management Platform
Sutter Health is among the first healthcare networks to partner with Onduo—a joint venture between Verily Life Sciences LLC, (formerly Google Life Sciences) and Sanofi—to support and simplify care for those with type 2 diabetes.
“This collaboration with Onduo further advances our work to develop engaging and incredibly personal care options for those with type 2 diabetes—and for their families—so they may live their very best lives,” said Chris Waugh, Sutter Health’s chief innovation officer. “Because our integrated network focuses on Northern California, where we care for one of the most diverse populations in the world, we offer partners like Onduo the unique opportunity to work with us to test treatments and tools in various care settings that can influence the care for people of all races and ethnicities.”
Initially, Onduo will focus on developing solutions that could help type 2 diabetics make better decisions about their day-to-day health, ranging from improved medication management to improved habits and goals. With Sutter Health’s support, Onduo will develop comprehensive solutions that combine devices, software, medicine and professional care. Over time, the company plans to expand its focus to include the type 1 diabetes community, and eventually to people at risk of developing diabetes with the goal of helping them better prevent the onset of the disease.
If you liked this article, you may also like:
Sutter Health Pilots Velano Vascular’s Innovative Needle-Free Blood Draw Technology Sutter Health and AstraZeneca form Research Collaboration to Transform Care for Diabetes and other Cardiometabolic Conditions Bringing Diabetes Education to Our Communities